Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pfizer
Hoffmann-La Roche
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Children's Oncology Group
Bayer
National Cancer Institute (NCI)
City of Hope Medical Center
Bristol-Myers Squibb
Children's Oncology Group
Novartis
Children's Oncology Group
National Institutes of Health Clinical Center (CC)
City of Hope Medical Center
Columbia University
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
Fred Hutchinson Cancer Center
Barbara Ann Karmanos Cancer Institute
University of South Florida
Dana-Farber Cancer Institute